Regeneron Announces Presentation at the 32nd Annual J. P. Morgan Healthcare Conference
TARRYTOWN, N.Y., Dec. 17, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 32nd Annual J. P. Morgan Healthcare Conference on Tuesday, January 14, 2014. The presentation is scheduled for 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time) and may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentation will be available for 30 days.
About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.
SOURCE Regeneron Pharmaceuticals, Inc.